Intellia Therapeutics, Inc. (NTLA) Revenue Growth
Intellia Therapeutics, Inc. (NTLA) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 58.49% |
| 2018-12-31 | 16.53% |
| 2019-12-31 | 41.63% |
| 2020-12-31 | 34.55% |
| 2021-12-31 | -43.01% |
| 2022-12-31 | 57.69% |
| 2023-12-31 | -30.40% |
| 2024-12-31 | 59.55% |
| 2025-12-31 | 16.92% |
How NTLA compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| IONS | Ionis Pharmaceuticals Inc. | 33.83% |
| MOH | Molina Healthcare Inc | 11.75% |
| VNDA | Vanda Pharmaceuticals Inc. | 8.72% |
| BKD | Brookdale Senior Living Inc. | 2.19% |
| MYGN | Myriad Genetics Inc. | -1.56% |
These are five companies in the same sector as NTLA with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Intellia Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("NTLA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NTLA | $12.74 | +0.47% | 2.79M |
| 3 | ||||
| 4 | ||||
| 5 |